RAGE is either expressed by tumor cells or infiltrating immune cells in the tumor microenvironment. Many of its ligands are also abundantly present in the same tissue niche. The activation of this multilgand receptor triggers different signaling cascades promoting stromal pro-tumoral phenotypical changes mediated by a myriad of mechanisms supporting tumor growth and development.